周三盘前，医疗保健巨头雅培（Abbott Laboratories）股价大跌5.41%，主要原因是公司公布的第三季度业绩未能达到分析师预期。
根据最新财报，雅培第三季度总营收为113.7亿美元，略低于分析师平均预期的114.0亿美元。其中，诊断部门的销售额下降了6.6%，为22.5亿美元，同样低于预期的22.9亿美元。这一业绩表现反映出公司在后疫情时代面临的挑战，特别是诊断设备需求的疲软。
尽管雅培的经调整后每股收益为1.30美元，符合分析师预期，但投资者似乎更关注公司整体收入的下滑。值得注意的是，雅培已经收窄了全年每股收益预期区间，从此前的5.10美元至5.20美元调整为5.12美元至5.18美元。这一举动可能暗示公司对未来几个月的业务前景持谨慎态度，进一步加剧了市场的担忧情绪。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.